A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseasesA gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.BioPharma DiveBen FidlerDNA origami signal amplification in lateral